1311.2.10010 Boehringer Ingelheim Investigational Site

Los Angeles, California

0 studies enrolling now · 1 studies all time

What they study most

Psoriasis

Studies at this site

• BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab — Completed